Preparation of endotoxin-free bacteriophages

• Autorzy: Boratynski J , Syper D. , Weber-Dabrowska B. , Lusiak-Szelachowska M. , Pozniak G. , Gorski A.
• Języki publikacji: EN

Abstrakty

EN

Bacteriophages (phages) are bacterial viruses that interact with bacterial walls and invade bacterial cells. Moreover, they disturb bacterial metabolism and lead to bacteria lysis. In the case of Gram-negative bacteria crude phage cultures, apart from the phages themselves, the bacterial debris, bacterial proteins and nucleic acids contain endotoxins. These endotoxins (lipopolysaccharides) posses a high degree of toxicity in vitro and in vivo, and their removal is essential for safety in antibacterial bacteriophage therapy. An effective, scaleable purification of bacteriophages from endotoxins was accomplished by sequential ultrafiltration through polysulfone membrane (30 nm) followed by chromatography on sepharose 4B and Matrex Cellulofine Sulfate. The phage fraction after gel filtration chromatography routinely contained endotoxins in the 150-2500 EU/mL range. The procedure yielded bacteriophages contaminated with as little as 0.4-7 EU/ml (Limulus assay). This value lies within the permitted level for intravenous applications (5 EU/kg/h by European Pharmacopoeia, 1997)

Słowa kluczowe

EN

bacteriophage; lipopolysaccharide; therapy; purification; endotoxin

• Wydawca: -
• Czasopismo: Cellular and Molecular Biology Letters
• Rocznik: 2004
• Tom: 09
• Numer: 2
• Opis fizyczny: p.253-259,ref.

Twórcy

autor

Boratynski J

• Polish Academy of Sciences, Rudolfa Weigla 12, 53-114 Wroclaw, Poland

autor

Syper D.

autor

Weber-Dabrowska B.

autor

Lusiak-Szelachowska M.

autor

Pozniak G.

autor

Gorski A.

Bibliografia

• 1. Knirel, Y.A., Kocharova, N.A., Bystrova, O.V., Katzenellenbogen, E. and Gamian, A. Structures and serology of the O-specific polysaccharides of bacteria of the genus Citrobacter. Arch. Immunol. Ther. Exp. 50 (2002) 379-391.
• 2. Frridge, C., Bennett-Guerrero, E. and Poxton, I.R. Structure and function of lipopolysaccharides. Microbes Infect. 4 (2002) 837-851.
• 3. Pabst, M.J. and Johnston, R.B. Bacterial LPS: A mediator of inflamation in: Handbook of Inflamation vol. 6 Elsevier Amsterdam (Henson, P.M. and Murphy, R.C. Eds.), 1989, 361-393.
• 4. Alexander, C. and Rietschel, E.T. Bacterial lipopolysaccharides and innate immunity. J. Endotoxin Res. 7 (2001) 167-202.
• 5. Rietschel, E.T., Kirikae, T., Schade, F.U., Mamat, U., Schmidt, G., Loppnow, H., Ulmer, A,J., Zahringer, U., Seydel, U., Di Padova, F., Schreier, M. and Brade, H. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 8 (1994) 217-225.
• 6. Fiuza, C. and Suffredini, A.F. Human models of innate immunity: local and systemic inflammatory responses. J. Endotoxin Res. 7 (2001) 385-388.
• 7. Martich, G.D., Boujoukos, A.J. and Suffredini, A.F. Response of man to endotoxin. Immunobiology 187 (1993) 403-416.
• 8. Fiske, M.J., Fredenburg, R.A., VanDerMeid, K.R., McMichael, J.C. and Arumugham, R. Method for reducing endotoxin in Moraxella catarrhalis UspA2 protein preparations. J. Chromatogr. B Biomed. Sci. Appl. 753 (2001) 269-278.
• 9. Wilson, M.J., Haggart, C.L., Gallagher, S.P. and Walsh, D. Removal of tightly bound endotoxin from biological products. J. Biotechnol. 88 (2001) 67-75.
• 10. Ding, J.L., Zhu, Y. and Ho, B. High-performance affinity capture-removal of bacterial pyrogen from solutions J. Chromatogr. B Biomed. Sci. Appl. 759 (2001) 237-246.
• 11. Wei, G.L., Liu, X.L., Li, J.H. Liu, Y. and Shang, Z.H. Endotoxin removal in some medicines and human serum albumin solution by affinity membranes. Se Pu. 20 (2002) 108-114.
• 12. Li, J., Shao, Y., Chen, Z., Cong, R., Wang, J. and Liu, X. Membrane cartridges for endotoxin removal from interferon preparations. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 791 (2003) 55-61.
• 13. Guo, W., Shang, Z., Yu, Y. and Zhou, L. Removal of endotoxin from aqueous solutions by affinity membrane. Biomed. Chromatogr. 11 (1997) 164-166.
• 14. McNeff, C., Zhao, Q., Almlof, E., Flickinger, M. and Carr, P.W. The efficient removal of endotoxins from insulin using quaternized polyethyleneimine-coated porous zirconia. Anal. Biochem. 274 (1999) 181187.
• 15. Hirayama, C., Sakata, M., Nakamura, M., Ihara, H., Kunitake, M. and Todokoro, M. Preparation of poly(epsilon-lysine) adsorbents and application to selective removal of lipopolysaccharides. J. Chromatogr. B Biomed. Sci. Appl. 721 (1999) 187-195.
• 16. Hirayama, C. and Sakata, M. Chromatographic removal of endotoxin from protein solutions by polymer particles. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 781 (2002) 419-432.
• 17. Salek-Ardakani, S., Stuart, A.D., Arrand, J.E., Lyons, S., Arrand, J.R. and Mackett, M. High level expression and purification of the Epstein-Barr virus encoded cytokine viral interleukin 10: efficient removal of endotoxin. Cytokine 17 (2002) 1-13.
• 18. Ullrich, H., Jakob, W., Frohlich, D., Rothe, G., Prasser, C., Drobnik, W., Taeger, K., Meier-Hellmann, A., Reinhart, K., Zimmermann, M. and Schmitz, G. A new endotoxin adsorber: first clinical application. Ther. Apher. 5 (2001) 326-334.
• 19. Bosch, T. Recent advances in therapeutic apheresis. J. Artif. Organs. 6 (2003) 1-8.
• 20. Uriu, K., Osajima, A., Hiroshige, K., Watanabe, H., Aibara, K., Inada, Y., Segawa, K., Anai, H., Takagi, I., Ito, A., Kamochi, M. and Kaizu, K. Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock. Am. J. Kidney Dis. 39 (2002) 937-947.
• 21. Teramoto, K., Nakamoto, Y., Kunitomo, T., Shoji, H., Tani, T., Hanazawa, K. and Kodama, M. Removal of endotoxin in blood by polymyxin B immobilized polystyrene-derivative fiber. Ther. Apher. 6 (2002) 103-108.
• 22. Takemoto, Y., Nakatani, T., Sugimura, K., Yoshimura, R. and Tsuchida, K. Endotoxin adsorption of various dialysis membranes: in vitro study. Artif.Organs. 27 (2003) 1134-1137.
• 23. Petsch, D. and Anspach, F.B. Endotoxin removal from protein solutions J. Biotechnol. 76 (2000) 97-119.
• 24. Hirayama, C. and Sakata, M. Chromatographic removal of endotoxin from protein solutions by polymer particles. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 781 (2002) 419-432.
• 25. Slopek, S., Durlakowa, I., Weber-Dabrowska, B., Kucharewicz-Krukowska, A., Dabrowski, M. and Bisikiewicz, R. Results of bacteriophage treatment of suppurative bacterial infections. I. General evaluation of the results. Arch. Immunol. Ther. Exp. 31 (1983) 267-291.
• 26. Zimecki, M., Weber-Dabrowska, B., Lusiak-Szelachowska, M., Mulczyk, M., Boratynski, J., Pozniak, G., Syper, D. and Gorski, A. Bacteriophages provide regulatory signals in mitogen-induced murine splenocyte proliferation. Cell. Mol. Biol. Lett. 8 (2003) 699-711.
• 27. O'Riordan, C.R., Lachapelle, A.L., Vincent, K.A. and Wadsworth, S.C. Scaleable chromatographic purification process for recombinant adeno-associated virus (rAAV). J. Gene Med. 2 ( 2000) 444-454.
• 28. Neil, P.F.O. and Blakovic, E.S. Virus harvesting and affinity-based liquid chromatography. A method for virus concentration and purification. Biotechnology 11 (1993) 173-176.
• 29. Gorski, A., Nowaczyk, M., Weber-Dabrowska, B., Kniotek, M., Boratynski, J., Ahmed, A., Dabrowska, K., Wierzbicki, P., Switala-Jelen, K. and Opolski, A. New insights into the possible role of bacteriophages in transplantation Transplant. Proc. 35 (2003) 2372-2373.
• 30. Gorski, A., Dabrowska, K., Switala-Jelen, K., Nowaczyk, M., Weber-Dabrowska, B., Boratynski, J., Wietrzyk, J. and Opolski, A. New insights into the possible role of bacteriophages in host defense and disease. Med. Immunol. 2 (2003) 2.